215 related articles for article (PubMed ID: 38238581)
61. Identification of M5c regulator-medicated methylation modification patterns for prognosis and immune microenvironment in glioma.
Xiao Z; Li J; Liang C; Liu Y; Zhang Y; Zhang Y; Liu Q; Yan X
Aging (Albany NY); 2023 Nov; 15(21):12275-12295. PubMed ID: 37934565
[TBL] [Abstract][Full Text] [Related]
62. Prognostic Value and Genome Signature of m6A/m5C Regulated Genes in Early-Stage Lung Adenocarcinoma.
Tian L; Wang Y; Tian J; Song W; Li L; Che G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047493
[TBL] [Abstract][Full Text] [Related]
63. Molecular Characterization Clinical and Immunotherapeutic Characteristics of m5C Regulator NOP2 Across 33 Cancer Types.
Liu T; Zhang J; Lin C; Liu G; Xie G; Dai Z; Yu P; Wang J; Guo L
Front Cell Dev Biol; 2022; 10():839136. PubMed ID: 35372330
[No Abstract] [Full Text] [Related]
64. Integrated multi-omic analysis and experiment reveals the role of endoplasmic reticulum stress in lung adenocarcinoma.
Liu Y; Lin W; Qian H; Yang Y; Zhou X; Wu C; Pan X; Liu Y; Wang G
BMC Med Genomics; 2024 Jan; 17(1):12. PubMed ID: 38167084
[TBL] [Abstract][Full Text] [Related]
65. ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma.
Wang ZZ; Meng T; Yang MY; Wang W; Zhang Y; Liu Y; Han AQ; Wu J; Wang HX; Qian B; Zhu LX
Transl Oncol; 2022 Jul; 21():101441. PubMed ID: 35523010
[TBL] [Abstract][Full Text] [Related]
66. The prognostic value and immune landscapes of m1A/m5C/m6A-associated lncRNA signature in osteosarcoma.
Wu ZY; Shi ZY
Eur Rev Med Pharmacol Sci; 2022 Aug; 26(16):5868-5883. PubMed ID: 36066162
[TBL] [Abstract][Full Text] [Related]
67. Pan-Cancer Analysis of PARP1 Alterations as Biomarkers in the Prediction of Immunotherapeutic Effects and the Association of Its Expression Levels and Immunotherapy Signatures.
Zhang X; Wang Y; A G; Qu C; Chen J
Front Immunol; 2021; 12():721030. PubMed ID: 34531868
[TBL] [Abstract][Full Text] [Related]
68.
Wang J; Li Y; Xu B; Dong J; Zhao H; Zhao D; Wu Y
Onco Targets Ther; 2021; 14():145-155. PubMed ID: 33447056
[TBL] [Abstract][Full Text] [Related]
69. Prognostic Significance and Tumor Immune Microenvironment Heterogenicity of m5C RNA Methylation Regulators in Triple-Negative Breast Cancer.
Huang Z; Pan J; Wang H; Du X; Xu Y; Wang Z; Chen D
Front Cell Dev Biol; 2021; 9():657547. PubMed ID: 33928086
[TBL] [Abstract][Full Text] [Related]
70. The role of the HIF-1α/ALYREF/PKM2 axis in glycolysis and tumorigenesis of bladder cancer.
Wang JZ; Zhu W; Han J; Yang X; Zhou R; Lu HC; Yu H; Yuan WB; Li PC; Tao J; Lu Q; Wei JF; Yang H
Cancer Commun (Lond); 2021 Jul; 41(7):560-575. PubMed ID: 33991457
[TBL] [Abstract][Full Text] [Related]
71. Tumor microenvironment-related gene selenium-binding protein 1 (SELENBP1) is associated with immunotherapy efficacy and survival in colorectal cancer.
Zhu C; Wang S; Du Y; Dai Y; Huai Q; Li X; Du Y; Dai H; Yuan W; Yin S; Wang H
BMC Gastroenterol; 2022 Oct; 22(1):437. PubMed ID: 36253721
[TBL] [Abstract][Full Text] [Related]
72. Multi-Omic Analyses of the m
Xue C; Zhao Y; Li G; Li L
Front Oncol; 2021; 11():633415. PubMed ID: 34367948
[TBL] [Abstract][Full Text] [Related]
73. Molecular Characterization and Clinical Characteristics of m5C-Based RNA Methylation in Spinal Cord Injury: Validated by qPCR.
Cao L; Pi WJ; Zhang Q; Li Q
Int J Genomics; 2022; 2022():5433860. PubMed ID: 36582430
[TBL] [Abstract][Full Text] [Related]
74. The RNA Methylation Modification 5-Methylcytosine Impacts Immunity Characteristics, Prognosis and Progression of Oral Squamous Cell Carcinoma by Bioinformatics Analysis.
Gao L; Chen R; Sugimoto M; Mizuta M; Zhou L; Kishimoto Y; Huang X; Omori K
Front Bioeng Biotechnol; 2021; 9():760724. PubMed ID: 34957065
[TBL] [Abstract][Full Text] [Related]
75. Involvement of RNA methylation modification patterns mediated by m7G, m6A, m5C and m1A regulators in immune microenvironment regulation of Sjögren's syndrome.
Liu Y; Zhu J; Ding L
Cell Signal; 2023 Jun; 106():110650. PubMed ID: 36935085
[TBL] [Abstract][Full Text] [Related]
76. Elevated mRNA Level of Y-Box Binding Protein 1 Indicates Unfavorable Prognosis Correlated with Macrophage Infiltration and T Cell Exhaustion in Luminal Breast Cancer.
Lv Z; Xue C; Zhang L; Sun J; Bo C
Cancer Manag Res; 2021; 13():6411-6428. PubMed ID: 34429650
[TBL] [Abstract][Full Text] [Related]
77. Promotion of colorectal cancer progression by immune-related lnc-SOX9-4 via suppression of YBX1 poly-ubiquitination and degradation.
Zhao Y; Yang S; Nie H; Zhang D; Wang T; Sun Q; Wang X; Sun Y
Cell Signal; 2023 Nov; 111():110854. PubMed ID: 37611648
[TBL] [Abstract][Full Text] [Related]
78. YBX1 promotes homologous recombination and resistance to platinum-induced stress in ovarian cancer by recognizing m5C modification.
Meng H; Miao H; Zhang Y; Chen T; Yuan L; Wan Y; Jiang Y; Zhang L; Cheng W
Cancer Lett; 2024 Jun; 597():217064. PubMed ID: 38880223
[TBL] [Abstract][Full Text] [Related]
79. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
80. Identification of putative reader proteins of 5-methylcytosine and its derivatives in
Navarro IC; Suen KM; Bensaddek D; Tanpure A; Lamond A; Balasubramanian S; Miska EA
Wellcome Open Res; 2022; 7():282. PubMed ID: 37475875
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
